Evidence map›Paper›PMID 33170174›Full record

ReviewActa bio-medica : Atenei Parmensis2020

Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19.

Aysha Karim Kiani, Kristjana Dhuli, Kyrylo Anpilogov, Simone Bressan, Astrit Dautaj, Munis Dundar, Tommaso Beccari, Mahmut C Ergoren, Matteo Bertelli

Abstract readReview
In one paragraph

Review in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Dietary supplements for the management of COVID-19 symptoms.Journal of preventive medicine and hygiene · 2022
    Review
  13. Foods of the Mediterranean diet: citrus, cucumber and grape.Journal of preventive medicine and hygiene · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aysha Karim KianiMAGI EUREGIO, Bolzano, Italy. ayshakiani@gmail.com.
Kristjana DhuliEBTNA-LAB, Rovereto (TN), Italy. support.genetica@assomagi.org.
Kyrylo AnpilogovMAGI'S LAB, Rovereto (TN), Italy. kirill.anpilogov@assomagi.org.
Simone BressanMAGI'S LAB, Rovereto (TN), Italy. simone.bressan@assomagi.org.
Astrit DautajEBTNA-LAB, Rovereto (TN), Italy. stefano.paolacci@assomagi.org.
Munis DundarDepartment of Medical Genetics, Erciyes University, Kayseri, Turkey. stefano.paolacci@assomagi.org.
Tommaso BeccariDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, Italy. stefano.paolacci@assomagi.org.
Mahmut C ErgorenDepartment of Medical Biology, Faculty of Medicine, Near East University, Nicosia, Cyprus; DESAM Institute, Near East University, Nicosia, Cyprus. stefano.paolacci@assomagi.org.
Matteo BertelliMAGI EUREGIO, Bolzano, Italy; EBTNA-LAB, Rovereto (TN), Italy; MAGI'S LAB, Rovereto (TN), Italy. matteo.bertelli@assomagi.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe recent COVID-19 pandemic caused by SARS-CoV-2 affected more than six million people and caused thousands of deaths. The lack of effective drugs or vaccines against SARS-CoV-2 further worsened the situation. This review is focused on the identification of molecules that may inhibit viral entry into host cells by endocytosis.

methodsWe performed the literature search for these natural compounds in the articles indexed in PubMed.

resultsNatural products against viral infections have been gaining importance in recent years. Specific natural compounds like phytosterols, polyphenols, flavonoids, citrus, galangal, curcuma and hydroxytyrosol are being analyzed to understand whether they could inhibit SARS-CoV-2.

conclusionsWe reviewed natural compounds with potential antiviral activity against SARS-CoV-2 that could be used as a treatment for COVID-19.

Indexed as

BetacoronavirusAntiviral AgentsBiological FactorsCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentEndocytosisHumansPandemicsPneumonia, ViralSARS-CoV-2Antiviral AgentsBiological Factors

Identifiers

PMID33170174
PMCPMC8023130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.